The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...

Recognition of the heterogeneous causes of diabetes should help improve prevention, treatment, and the ability to predict ...

Contrary to concerns, GLP-1RA medications don’t appear to elevate AKI risk in patients undergoing cancer treatment.

A minorities-only study on a dual-action therapy for diabetic macular edema found Hispanic and Latino patients not only ...

Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits ...

The diabetes drug semaglutide, also known as Ozempic, has a positive effect for patients with chronic kidney damage and obesity. They ...

A Bend diabetologist, Dr. Eden Miller, has Type 1 diabetes herself, making her patients experience with new high-tech ...

A new treatment combining ReCET and semaglutide could eliminate the need for insulin in type 2 diabetes, with 86% of ...

Some people with diabetes have been charged for their "free" continuous glucose monitors, which have been fully ...

The experimental therapy takes just a few weeks and removed insulin from the equation for 86% of trial participants.

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 ...